Scott Hutton - 01 Mar 2023 Form 4 Insider Report for BIODESIX INC (BDSX)

Reporting relationship: President & CEO, Director
Issuer ticker: BDSX
Reported as of: 01 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2023, 15:16:33 UTC
Prior SEC filing: 10 Feb 2023
Next SEC filing: 10 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton

Key filing fact

Scott Hutton filed Form 4 for BIODESIX INC (BDSX) on 03 Mar 2023.

Key facts

This page summarizes Scott Hutton's Form 4 filing for BIODESIX INC (BDSX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2023, 15:16.

Change

Previous filing in this sequence was filed on 10 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BDSX transaction Derivative

Stock Options (Right to buy)

Award

Transaction value: $0
Shares: +435,668
Change %
Price: $0.000000
Shares after: 435,668
Date: 01 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 435,668
Exercise price: $2.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option vested in full on March 1, 2023. Under the Issuer's 2022 Bonus-to-Options Program, the Reporting Person elected to receive a portion of the annual cash bonus earned during 2022 in the form of a fully-vested option.